Basal Thumb Arthritis: Bracing Before Rebuilding the Joint

What is actually worn out at the base of the thumb?

The joint at the base of the thumb is a saddle: two curved surfaces sitting across each other so the thumb can swing, rotate, and oppose the fingers. That mobility is bought with load. Every pinch multiplies force across a small contact area, so when the cartilage there thins, the pain arrives at exactly the tasks that made the thumb worth having.

The joint has a formal name — the carpometacarpal (CMC) joint, where the thumb's first metacarpal meets the trapezium, a small block of wrist bone. Clinicians also call it the basal joint, and thumb basal joint arthritis is the same condition under a different label. What is happening inside it is osteoarthritis: the most common form of arthritis, a degenerative disease in which cartilage breaks down, becoming more common with age and, in women, after about 50 1Ref 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2023).Osteoarthritis.Osteoarthritis is the most common form of arthritis, a degenerative joint disease involving cartilage breakdown, more common with age and in women after about age 50 — used for the lay definition of what is wearing out at the thumb's basal joint..

Scale explains how much confident and contradictory advice circulates about this joint. About 58.5 million US adults — roughly one in four — have doctor-diagnosed arthritis, and about 25.7 million report that it limits what they do 2Ref 2Theis KA, Murphy LB, Guglielmo D, et al. (CDC/MMWR) (2021).Prevalence of Arthritis and Arthritis-Attributable Activity Limitation — United States, 2016-2018.US prevalence figures: about 58.5 million US adults (23.7%) had doctor-diagnosed arthritis in 2016-2018 and about 25.7 million reported arthritis-attributable activity limitation — used to size the population inside which thumb CMC osteoarthritis sits.. CMC joint osteoarthritis is one thread inside that number.

Is it the joint, or the tendons next to it?

Two very different problems sit within a thumb's width of each other, and they are routinely confused. Arthritis is inside the joint: the pain is deep, at the base, worst when you pinch or twist, and often paired with a grinding you can feel through the skin. De Quervain's tenosynovitis is in the tendon sheath just above it: the pain sits on the thumb side of the wrist and flares when you lift or wring.

The distinction matters because the two respond to different things. A tendon sheath problem often settles with rest, a different splint, and time. A worn joint surface does not settle in the same way. This is the general question of arthritis vs tendinitis vs bursitis playing out in about two centimetres of hand, and the point of the joint vs soft tissue pain distinction is that it changes the plan rather than the wording.

In the office the separation is made by hand, not by scan: pressing and rotating the metacarpal against the trapezium provokes the joint, while tucking the thumb into the fist and tilting the wrist away pulls the tendon sheath. An x-ray then shows how much joint surface is left — though what it shows and what the hand can do are frequently out of step, in both directions.

What a splint actually does

A thumb splint does not regrow cartilage, and nobody serious claims it does. What it does is mechanical: it holds the joint in a position that keeps the small stabilizing muscles from fighting each pinch, which takes load off an irritated joint lining. That is a testable claim — within a few weeks the splint has either made the painful tasks tolerable or it has not.

Load change is the other half, and it is the half that gets skipped. The joint responds to how force reaches it, so the practical work is removing the multipliers:

• Fat handles instead of thin ones — a pen, a peeler, a toothbrush with a built-up grip loads the joint less.
• Tools that replace pinch with a whole hand: a jar opener, a key turner, a lever tap.
• Two hands where one used to do — the kettle, the pan, the laptop.

A splint that lives in a drawer and a grip change nobody made are not a failed trial of conservative care. They are an untried one.

Does a steroid injection help, and for how long?

An injection into the thumb base can quiet a flare, and for some people that is enough to get a splint and a grip change working. The honest limit is that short-term relief and one-year outcome are different questions, and a treatment can win the first while losing the second. That is not a hypothetical worry. It has been measured directly, at a different site.

In a randomized trial of tennis elbow — a tendon problem at the elbow, not arthritis at the thumb — corticosteroid injection produced worse outcomes at one year and higher recurrence than a placebo injection, and adding physiotherapy made no significant difference by that point 3Ref 3Coombes BK, Bisset L, Brooks P, Khan A, Vicenzino B (2013).Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia: A Randomized Controlled Trial.In lateral epicondylalgia (tennis elbow), corticosteroid injection produced worse one-year outcomes and higher recurrence than placebo injection, and physiotherapy added no significant benefit at one year — used, explicitly as elbow-tendon evidence rather than a thumb verdict, to distinguish short-term relief from one-year outcome.. That result does not transfer to the thumb as a verdict; the tissue is different and the trial was not run here. What transfers is the shape of the question, and it is worth asking out loud before the needle: what does this look like at a year, and how many is too many?

An injection that works at six weeks and an injection that works at a year are two different findings, and the first is the one people remember.

What the operations do, and what they trade

The common operation removes the trapezium — the wrist bone the thumb grinds against — so there is no longer a worn surface to load. Surgeons then variously reconstruct a ligament, pack the space with a rolled tendon, or leave the space alone. Fusing the joint is a second route, trading motion for a stable, load-tolerant thumb. Implants exist as a third. All of them are irreversible in the plain sense that the bone does not come back.

The trade is not mostly about risk. It is about time and strength: recovery runs in months rather than weeks, with splinting and hand therapy through most of it, and pinch strength is the last thing to return. Many people are content with it — a weaker thumb that does not hurt beats a stronger one that does — but it is a trade, and worth naming before rather than after.

When several plausible operations for one problem are finally compared head to head, they tend to land closer together than their advocates expect. In primary frozen shoulder, a trial running early physiotherapy against manipulation under anaesthesia against arthroscopic capsular release found broadly similar outcomes at twelve months, with more complications after release and manipulation the most cost-effective 4Ref 4Rangan A, Brealey SD, Keding A, et al. (UK FROST) (2020).Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial.In primary frozen shoulder, physiotherapy, manipulation under anaesthesia, and arthroscopic capsular release gave broadly similar 12-month patient-reported outcomes, with more complications after arthroscopic release and manipulation most cost-effective — used, explicitly as shoulder evidence, to show that when options land together the tiebreak becomes burden, complications, and cost.. Frozen shoulder is not thumb arthritis. The transferable part is the tiebreak: when options land together, what separates them is burden, complications, and cost — not which sounds most definitive.

When surgery is clearly the right call

Sequence-of-care thinking is not an argument against operating. It is an argument about order, and it has an end. Surgery at the thumb base earns its place when the joint surface is gone on x-ray, the pain stops waiting for a task and shows up at rest or at night, pinch fails at things that matter — a key, a jar, a pen — and a genuine trial of splinting and load change has already run.

The features that generally move the conversation toward the operating room:

• Radiographic joint destruction plus matching symptoms. Not the x-ray alone, and not the pain alone. The two agreeing is the signal.
• Rest and night pain, which has left the territory a splint governs.
• Functional pinch failure despite the trial — the hand cannot do what the person needs, with the splint worn and the grips changed.
• A fixed deformity. When the thumb sits adducted and the web space tightens, the mechanics are no longer correctable from outside.

Three situations point elsewhere entirely. A joint that turns hot and swollen over hours is an infection or crystal question. Multiple joints stiff each morning, symmetrically, points toward inflammatory arthritis. And numbness in the thumb, index, and middle fingers that wakes someone at night is a nerve at the wrist — the carpal tunnel surgery vs splint decision runs on similar logic but on entirely different tissue.

Why the trial of conservative care is not stalling

The worry underneath "let's try the splint first" is that it is a delay dressed as a plan — that a year gets spent on half-measures and the operation happens anyway, later and no better. Trials elsewhere in orthopaedics do not support that fear as a general rule, and the reason is structural: conservative care is not a waiting room. It is a treatment that a substantial share of people never need to leave.

The clearest demonstration comes from a knee ligament, not a thumb. In young active adults with acute anterior cruciate ligament tears, rehabilitation plus early reconstruction was not superior to rehabilitation with optional delayed reconstruction, and about half the rehabilitation-first group avoided surgery altogether without worse two-year outcomes 5Ref 5Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS (KANON) (2010).A Randomized Trial of Treatment for Acute Anterior Cruciate Ligament Tears.In young active adults with acute ACL tears, rehabilitation plus early reconstruction was not superior to rehabilitation with optional delayed reconstruction, and about half the rehabilitation-first group avoided surgery without worse two-year outcomes — used, explicitly as knee-ligament evidence, to support the claim that a conservative-first trial preserves the surgical option rather than wasting time.. An ACL is not a worn saddle joint, and nothing there predicts a thumb. What it establishes is that "try this first" can preserve the option to operate while costing the group nothing measurable.

The practical version: run the trial properly and put a date on it. A splint actually worn, grips actually changed, an injection if a flare needs breaking — and a review at a defined point rather than an open-ended drift. If the thumb improved enough to live with, that was the treatment working. If it did not, the trial has done its second job: making the case for the operation unambiguous rather than hopeful.